Chronic pain, defined as pain existing for >4-6 weeks, affects >60% of patients with autosomal-dominant polycystic disease (ADPKD). It can have various causes, indirectly or directly related to the increase in kidney and liver volume in these patients. Chronic pain in ADPKD patients is often severe, impacting physical activity and social relationships, and frequently difficult to manage. This review provides an overview of pathophysiological mechanisms that can lead to pain and discusses the sensory innervation of the kidneys and the upper abdominal organs, including the liver. In addition, the results of a systematic literature search of ADPKD-specific treatment options are presented. Based on pathophysiological knowledge and evidenc...
Background: Pain affects 60% of the autosomal dominant polycystic kidney disease (ADPKD) population....
Pain is a common symptom in people with autosomal dominant polycystic kidney disease (ADPKD), but it...
Pain has been reported to be a common problem in the general population and end-stage renal disease ...
Chronic pain, defined as pain existing for >4-6 weeks, affects >60% of patients with autosomal...
Autosomal Dominant Polycystic Kidney Disease (ADPKD), often referred to as 'adult' polycystic kidney...
Pain is a common symptom in people with autosomal dominant polycystic kidney disease (ADPKD), but it...
Pain management in polycystic kidney disease. Pain is a common complaint in patients with autosomal-...
Pain is a common symptom in people with autosomal dominant polycystic kidney disease (ADPKD), but it...
Purpose Chronic pain is a prominent feature of autosomal dominant polycystic kidney disease that ...
Chronic pain is a common concern in patients with autosomal dominant polycystic kidney disease (ADPK...
Item does not contain fulltextAutosomal dominant polycystic kidney disease (ADPKD) patients can suff...
Pain patterns in patients with polycystic kidney disease.BackgroundPain is a common problem in patie...
There is increasing international attention in efforts to integrate palliative care principles, incl...
Background. Pain is the highest prioritized patient-reported outcome in people with autosomal domin...
peer reviewedAutosomal dominant polycystic kidney disease (ADPKD) is characterized by the developmen...
Background: Pain affects 60% of the autosomal dominant polycystic kidney disease (ADPKD) population....
Pain is a common symptom in people with autosomal dominant polycystic kidney disease (ADPKD), but it...
Pain has been reported to be a common problem in the general population and end-stage renal disease ...
Chronic pain, defined as pain existing for >4-6 weeks, affects >60% of patients with autosomal...
Autosomal Dominant Polycystic Kidney Disease (ADPKD), often referred to as 'adult' polycystic kidney...
Pain is a common symptom in people with autosomal dominant polycystic kidney disease (ADPKD), but it...
Pain management in polycystic kidney disease. Pain is a common complaint in patients with autosomal-...
Pain is a common symptom in people with autosomal dominant polycystic kidney disease (ADPKD), but it...
Purpose Chronic pain is a prominent feature of autosomal dominant polycystic kidney disease that ...
Chronic pain is a common concern in patients with autosomal dominant polycystic kidney disease (ADPK...
Item does not contain fulltextAutosomal dominant polycystic kidney disease (ADPKD) patients can suff...
Pain patterns in patients with polycystic kidney disease.BackgroundPain is a common problem in patie...
There is increasing international attention in efforts to integrate palliative care principles, incl...
Background. Pain is the highest prioritized patient-reported outcome in people with autosomal domin...
peer reviewedAutosomal dominant polycystic kidney disease (ADPKD) is characterized by the developmen...
Background: Pain affects 60% of the autosomal dominant polycystic kidney disease (ADPKD) population....
Pain is a common symptom in people with autosomal dominant polycystic kidney disease (ADPKD), but it...
Pain has been reported to be a common problem in the general population and end-stage renal disease ...